EAS Newsletter November 28, 2023

EAS Governance:

Announcing the 2024 Anitschkow Prize recipient

The European Atherosclerosis Society is delighted to announce Professor Bart Staels as the recipient of the 2024 Anitschkow Award. The Award recognises his outstanding contributions to the fields of metabolic and cardiovascular disease, in particular his research into the role of nuclear receptors in the control of inflammation and lipid and glucose homeostasis.

EAS Society:

Are you seeking a reputable society in your field?: introducing the new membership process

Are you interested in becoming an EAS member? Are you seeking a reputable society in your field? Let’s achieve it together.

Join us by submitting documents confirming your interest. Starting in 2024, we strengthen our community, accepting only those genuinely interested in our field. It will involve simply uploading two documents for joining us, but then the list of benefits for EAS members is extremely huge. Despite the fact that the membership fee is increasing concurrently, it is evident that the diverse activities we offer have a substantial value.

EAS Congress:

Registration for the 92nd EAS Congress is open

We are thrilled to invite you to participate in the 92nd EAS Congress in the beautiful city of Lyon, France! The Congress will take place on May 26-29, 2024.

During the meeting we will explore the latest developments in basic, translational and clinical research into the causes of atherosclerosis and related vascular disease, and how these may affect the clinical guidelines for diagnosis and treatment. One of the key features of our Congress is the high-level interdisciplinary exchange between clinicians and basic researchers.

Mark your calendars and stay tuned!

EAS Governance:

Submit your abstract for the EAS Congress 2024 and apply for Young Investigator Fellowships and Travel Grants

Time is ticking, and many individuals are eager to seize this opportunity to engage in the exchange of fresh research and ideas with scientists from around the globe. It’s a unique chance to participate in the distinctive 92nd EAS Congress.

Make sure to explore the possibilities related to Young Investigator Fellowships and Travel Grants. Further details are provided below.

Remember, the deadline for submission is December 5, 2023. Act now!

EAS Education:

Featured Plenary Session from EAS Congress 2023: Advancing therapy

This week, we’ve chosen the third plenary session on Advancing therapy from the EAS Congress 2023 in Mannheim for you.

Customize your learning experience to fit your schedule and embark on a lifelong learning journey with the EAS Academy.

Access the lecture by clicking on the image.

Sekar Kathiresan is co-founder, chief executive officer and a member of the company’s board of directors of Verve Therapeutics. Prior to joining Verve, he served as Director of the Massachusetts General Hospital (MGH) Center for Genomic Medicine and was the Ofer and Shelly Nemirovsky MGH Research Scholar. He also served as Director of the Cardiovascular Disease Initiative at the Broad Institute and was Professor of Medicine at Harvard Medical School. His research focused on understanding the inherited basis for blood lipids and myocardial infarction (MI) and using these insights to improve preventive cardiac care. Among his scientific contributions, Dr. Kathiresan helped to highlight new biological mechanisms underlying MI, discovered mutations that protect against MI risk, and developed a genetic test for personalized MI prevention.

Dr. Kathiresan completed a Bachelor of Arts in history from the University of Pennsylvania and a medical degree from Harvard Medical School. He undertook clinical training in internal medicine and cardiology at MGH and postdoctoral research training in human genetics at the Framingham Heart Study and the Broad Institute.

Khurram Nasir is Professor of Cardiology, Academic Institute, Chief, Division of Cardiovascular Prevention and Wellness, Department of Cardiology and Co-director, Center for Health Data Science and Analytics, Houston Methodist and Weill Cornell Medical College, USA. His research aims to identify the at-risk population to enable treatments to better targeted.

Dr. Nasir completed his medical degree in Pakistan, followed by a Master of Public Health degree at John Hopkins University. He undertook a residency at Boston Medical Center, a cardiology fellowship at Yale University, postdoctoral research training at the Division of Cardiology, Johns Hopkins Hospital, a fellowship in cardiac imaging at Massachusetts General Hospital, and a Master’s degree in Health Economics and Policy Management from the London School of Economics & Political Science, UK.

Manolis Kellis is Professor of Computer Science at Massachusetts Institute of Technology (MIT), a member of the Broad Institute of MIT and Harvard, and a member of the Computer Science and Artificial Intelligence Laboratory at MIT where he directs the MIT Computational Biology Group.

A major focus of his work is understanding the effects of genetic variation on various human diseases, including obesity, diabetes, Alzheimer’s disease and cancer. Specifically, his research focuses on i) genome interpretation, aiming to develop comparative genomics methods to identify genes and regulatory elements in the human genome; ii) gene regulation; iii) epigenomics, aiming to understand the chromatin signatures associated with distinct activity states, and the changes in these states across different cell types and during differentiation; and iv) evolutionary genomics, aiming to understand the dynamics of gene phylogenies across complete genes.

Pam R. Taub, MD is Professor of Medicine at the University of California (UC) San Diego School of Medicine in the Division of Cardiovascular Medicine. She is the Founding Director of the Step Family Foundation Cardiac Rehabilitation and Wellness Center. Her ongoing research focuses on the impact of daily fasting on cardiometabolic parameters and on mitochondrial function; biomarkers for cardiovascular risk factor stratification; wearable/mobile devices for improving cardiovascular outcomes; and the impact of epicatechin (compound in dark chocolate) on mitochondrial function/cellular bioenergetics and exercise capacity.

Dr. Taub completed her medical degree from Boston University School of Medicine, her residency at the University of Washington Medical Center in Seattle and her fellowship in cardiovascular medicine at UC San Diego. She is a fellow of the American College of Cardiology and a fellow and board member for the American Society of Preventive Cardiology.

EAS Education:

The new application process for the EAS Young Fellows programme starts in January 2024

The EAS Young Fellows programme is the Society’s flagship educational and networking activity.

Every other year we open applications for enthusiastic and committed young scientists to join the next class. Members seeking to apply should be early in their career, aged under 40, and should have made some progress in basic or clinical research, with at least one publication. A firm commitment to follow a career in the field of atherosclerosis and related disease is required.

The programme takes place over two years and will take the form of both online and face-to-face activities as circumstances allow.

The upcoming class is scheduled to commence in 2024, with the application process set to begin in January of the same year. Stay tuned!

EAS Collaborations:

10th Panhellenic Congress of the Working Groups of the Hellenic Atherosclerosis Society, December 1-2

On Saturday, December 2, 2023, the 10th Panhellenic Congress of the Working Groups will host a joint session with the European Atherosclerosis Society and African National Societies from 12:30 to 14:30 EET.

Additionally, don’t miss Professor Alberico Catapano’s keynote lecture in memory of Professor M. Elisaf on the same day, scheduled for 20:00 to 20:30. We invite you to join us for this collaborative event, fostering discussions among diverse stakeholders in the realms of health and society.

EAS Collaborations:

20th European Angiology Days, International Vascular Medicine Academic Yearly Conference, December 1-3

The upcoming 20th European Angiology Days, International Vascular Medicine Academic Yearly Conference is set to feature over 80 speakers representing 27 countries. The summit boasts a diverse program, including contributions from a WHO Europe representative and joint sessions with leading organizations like EAS.

The event provides a unique platform for global collaboration, offering insights into cutting-edge research, education, and the celebration of excellence in vascular medicine.

Join us for an insightful joint session VAS-EAS: Arterial Calcification

Chairpersons: Alberto Zambon (IT) and Renata Cifkova (CZ)

Speakers and Topics:

Pathobiology of Arterial Calcification: Interaction with Atherosclerosis

Speaker: Cathy M Shanahan (UK)

Epidemiology and Clinical Relevance

Speaker: Martin Bodtker Mortensen (DK)

Medial Arterial Calcification: Clinical Impact on Peripheral Arteries

Speaker: Peter Lanzer (DE)

Diabetes and Arterial Calcifications

Speaker: Michael Edmonds (UK)